Home Intravenous Antibiotic Therapy (HIVAT) for adult bronchiectasis patients: safe, efficacious and cost-effective

H. Chen (Middlesbrough, United Kingdom), H. Simmons (Middlesbrough, United Kingdom), V. Bradshaw (Middlesbrough, United Kingdom), S. Kalam (Middlesbrough, United Kingdom), E. Kane (Middlesbrough, United Kingdom), G. Antunes (Middlesbrough, United Kingdom)

Source: Virtual Congress 2021 – Bronchiectasis
Session: Bronchiectasis
Session type: E-poster
Number: 2063

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Chen (Middlesbrough, United Kingdom), H. Simmons (Middlesbrough, United Kingdom), V. Bradshaw (Middlesbrough, United Kingdom), S. Kalam (Middlesbrough, United Kingdom), E. Kane (Middlesbrough, United Kingdom), G. Antunes (Middlesbrough, United Kingdom). Home Intravenous Antibiotic Therapy (HIVAT) for adult bronchiectasis patients: safe, efficacious and cost-effective. 2063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Practical treatment of community acquired pneumonia (CAP) with outpatient parenteral antibiotic therapy (OPAT) and switch therapy: CTRX and LVFX
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008


Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011


Opportunities of application of short regimens for MDR-TBat the expense of using intravenous administration of anti-TB drugs during intensive phase
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Inhaled hypertonic saline as an adjunct to respiratory physiotherapy in UK paediatric lung transplant patients
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015


Home intravenous antibiotic treatments in cystic fibrosis adult patients
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002

Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


A community-based intravenous medication service has proven to be safe, effective and cost-effective for patients with acute respiratory illness
Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Year: 2010


Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


Palliative care for people with COPD: effective but underused
Source: Eur Respir J, 51 (2) 1702645; 10.1183/13993003.02645-2017
Year: 2018



Once-daily inhaled corticosteroids in children with asthma: Not a simple solution for non-adherence
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015


Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Debate: Antibiotic treatment is contraindicated in acute bronchitis - CON
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008



Is parenteral adrenaline used unnecessarily in the treatment of asthma patients in the pre-hospital setting?
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Year: 2014


Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019



Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019



Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016